Starting Weight Loss Treatment When You Live With Depression

Posted on November 16, 2026 by Sally-Anne Turner

Starting Weight Loss Injections With Depression: Assessment, Safety and Support

You've been managing depression for months or years. Perhaps you're taking antidepressants that have helped stabilise your mood but may have contributed to weight gain. Maybe you've struggled with both depression and weight for so long that they feel inseparable. Now you're considering weight loss injections like Wegovy or Mounjaro, but you're uncertain. Will starting treatment make your depression worse? Can you access these medications with a mental health history? What happens if you experience mood changes during treatment?

These questions deserve clear, evidence-based answers. Starting weight loss treatment when you live with depression is possible, but it requires appropriate assessment and consideration of your individual circumstances.

Importantly, the MHRA has reviewed concerns about depression and suicidal thoughts associated with GLP-1 medicines and concluded that the available evidence does not support a causal association. However, any new or worsening mental health symptoms still deserve attention.

This guide explores what to expect from the assessment process, how treatment may be monitored and how to approach weight management while protecting your mental health.

Understanding the Connection Between Depression and Weight

Before exploring the treatment process, it's worth understanding why depression and weight concerns sometimes occur together.

The relationship is complex, involving biological, psychological, behavioural and medication-related factors.

The Biological Links

Depression can affect appetite, sleep, motivation and energy levels.

Some people experience increased appetite during depression, while others lose interest in food or experience weight loss.

Researchers have also investigated relationships between depression, inflammation, metabolism and obesity.

Some studies suggest that depression and obesity may influence one another, although the mechanisms are not fully understood.

It would be inaccurate to suggest that depression consistently causes increased dopamine-driven comfort eating or that inflammation inevitably creates a cycle of worsening depression and weight gain.

Individual experiences vary considerably.

Medication Effects

Weight gain is a recognised potential side effect of some antidepressants.

Medicines including mirtazapine and certain selective serotonin reuptake inhibitors (SSRIs) may contribute to weight changes, although the likelihood and extent vary.

Other antidepressants may have different effects on appetite and weight.

It would be inaccurate to claim that all antidepressants slow metabolism or that everyone taking sertraline, citalopram or venlafaxine will gain weight.

If you've noticed weight changes after starting antidepressants, discuss them with your prescriber.

Your clinician can consider whether medication, depression symptoms or other factors may be contributing.

Weight-management medication may be appropriate for some patients who meet the relevant prescribing criteria, but it is not automatically indicated for antidepressant-associated weight gain.

Never stop or change antidepressant medication independently to manage your weight.

The Psychological Cycle

Depression can affect motivation, concentration and energy.

Everyday activities such as preparing meals, shopping or being physically active may become more difficult.

Some people also use food for emotional comfort, although this isn't a universal feature of depression.

Changes in weight can affect confidence and body image, particularly where someone has experienced weight stigma.

For some people, these concerns may contribute to additional emotional distress.

However, weight gain does not inevitably worsen depression, and weight loss does not necessarily improve it.

Addressing physical and psychological health together may help support overall wellbeing.

The Initial Assessment: What to Expect

When you contact a clinic like Bodyline about weight loss treatment, a history of depression does not automatically disqualify you.

However, your mental health is an important part of assessing whether treatment is appropriate.

Pre-Consultation Questionnaires

Before your consultation, you may be asked to provide information about your medical and mental health history.

This could include current diagnoses, medications, previous treatment and any relevant history of self-harm or suicidal thoughts.

The questions help your healthcare provider understand your individual circumstances.

It's important to provide accurate information, even if discussing your mental health feels uncomfortable.

A history of depression does not automatically mean that GLP-1 treatment is unsafe.

However, knowing about your symptoms and treatment history helps clinicians make informed prescribing decisions.

The Consultation Discussion

During your consultation, your clinician may ask about your depression and how it currently affects your life.

They might discuss your mood, sleep, appetite, energy levels and ability to manage everyday activities.

If you're taking antidepressants, your clinician should review the medication, dose and any relevant side effects.

They may also consider whether your depression is currently well managed or whether further mental health support is needed.

The discussion should be collaborative, allowing you to raise concerns and ask questions.

For more context, our guide on weight loss injections and mental health explores the broader considerations involved.

Assessment of Current Stability

Your current mental health is an important consideration when planning treatment.

Someone whose depression is well managed may have different needs from someone experiencing severe symptoms or an acute mental health crisis.

However, there is no universal MHRA requirement for patients to be free from depression or suicidal thoughts for a specified period before receiving GLP-1 medication.

Treatment suitability should be assessed individually.

If you're experiencing severe depression or an immediate risk of self-harm, urgent mental health assessment and treatment should take priority.

Your clinician may recommend postponing weight-management medication while these concerns are addressed.

This does not necessarily mean treatment will be inappropriate in future.

Risk Stratification

Your healthcare provider may consider factors that influence the level of support or monitoring you need.

These could include current depression symptoms, previous episodes, medication history, other health conditions and available support.

However, there is no universal MHRA risk classification system that places people with depression into low-, moderate- or high-risk categories specifically for GLP-1 treatment.

Any assessment framework should reflect the clinic's clinical procedures and individual patient needs.

A previous episode of depression or suicidal thoughts does not automatically determine treatment eligibility.

Coordination with Existing Providers

If you're receiving support from a psychiatrist, psychologist, GP or mental health team, communication between healthcare professionals may be helpful.

With your consent, relevant information can be shared to support coordinated care.

This may include your current medications, mental health treatment and any concerns requiring monitoring.

The NICE guideline on depression in adults supports coordinated care and appropriate monitoring for people receiving depression treatment.

However, not every patient with depression requires specialist psychiatric involvement before starting weight-management medication.

The level of coordination should depend on individual clinical circumstances.

Treatment Planning With Depression in Mind

Once treatment suitability has been established, your healthcare provider can discuss the available options.

For someone with depression, this may involve considering current medication, mental health symptoms and any additional support needs.

Medication Selection and Dosing

Wegovy contains semaglutide, a GLP-1 receptor agonist.

Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors.

Both medicines have licensed weight-management indications in the UK, subject to eligibility criteria.

They are generally started at lower doses and increased according to their individual prescribing schedules.

Gradual dose escalation helps improve gastrointestinal tolerability.

However, there is no universal MHRA recommendation to use a slower dose-escalation schedule solely because someone has depression.

Any changes to the standard schedule should be clinically appropriate and consistent with the medicine's prescribing information.

Enhanced Monitoring Schedule

Monitoring is an important part of medical weight management.

For someone with depression, this may include discussing changes in mood alongside weight, treatment response and physical side effects.

Some patients may benefit from additional contact, particularly if they have ongoing mental health symptoms.

However, there is no universal requirement for people with depression to attend more frequent GLP-1 monitoring appointments or follow a specific three-month enhanced monitoring programme.

The appropriate schedule depends on clinical circumstances.

Your healthcare provider may also use recognised questionnaires, such as the PHQ-9, where appropriate.

These can support assessment but should not replace clinical judgement.

Safety Planning

If you have experienced significant depression or suicidal thoughts, discussing a mental health safety plan may be helpful.

This could include recognising warning signs, identifying people you can contact and knowing how to access urgent support.

A safety plan may already form part of your existing mental health care.

It is not a mandatory requirement for every person with depression who starts GLP-1 treatment.

However, understanding when and where to seek help is important.

Psychological Support Integration

Weight-management medicines are intended to be used alongside appropriate dietary and physical activity measures.

Psychological support may also be beneficial, particularly where depression affects eating patterns, motivation or body image.

Cognitive behavioural therapy (CBT) can help address depression and certain unhelpful thought patterns.

Some people may benefit from counselling or other psychological interventions.

However, psychological therapy is not universally required before starting GLP-1 medication, and it would be inaccurate to claim that combining therapy with weight loss injections has been proven to prevent depression during treatment.

The most appropriate support depends on your individual needs.

Starting Treatment: The First Few Weeks

The first few weeks of treatment can involve changes in appetite and gastrointestinal symptoms.

Understanding potential side effects can help you recognise when medical advice is needed.

Common Physical Side Effects and Mood

Nausea, vomiting, diarrhoea and constipation are recognised side effects of GLP-1-based medicines.

Some people also experience fatigue.

Physical discomfort may affect everyday wellbeing, particularly if you're already experiencing depression-related tiredness or reduced motivation.

However, these symptoms should not automatically be interpreted as worsening depression.

Equally, new or worsening mood symptoms should not be dismissed as ordinary medication adjustment.

Gastrointestinal side effects may improve as treatment continues, but there is no guarantee that they will resolve within two to four weeks.

Persistent vomiting or diarrhoea can cause dehydration and requires medical advice.

Severe, persistent abdominal pain, particularly if it radiates to the back, requires urgent assessment because it may indicate acute pancreatitis.

The MHRA's guidance on GLP-1 medicines for weight loss and diabetes provides further information about these medicines and their safety considerations.

The Emotional Eating Challenge

If you've previously used food to cope with difficult emotions, changes in appetite may affect your eating habits.

Some people find that reduced hunger makes certain eating patterns easier to manage.

Others may notice that emotional difficulties remain even when their appetite changes.

However, GLP-1 medication does not necessarily remove the comfort associated with food or cause emotional instability.

These experiences vary between individuals.

If emotional eating is affecting your wellbeing, psychological support may help you develop additional coping strategies.

This might include relaxation techniques, enjoyable activities, social support or appropriate therapy.

Our article on weight loss injections and binge eating explores related considerations.

Distinguishing Adjustment From Depression

Starting a new medication may involve physical changes, but there is no established GLP-1 adjustment syndrome involving temporary low mood or emotional flatness.

If you experience new or worsening depression symptoms, they should be assessed rather than assumed to be temporary.

Symptoms may include persistent low mood, loss of interest in activities, changes in sleep, reduced concentration, feelings of hopelessness or thoughts of self-harm.

Some symptoms, including fatigue and appetite changes, can overlap with medication side effects.

This can make it difficult to identify the cause without clinical assessment.

If you're concerned about changes in your mood, contact your healthcare provider.

What Your Monitoring Appointments Will Cover

Monitoring appointments may include reviewing weight-management progress, medication tolerability and any new health concerns.

If you have depression, your clinician may also ask about mood, sleep, motivation and relevant changes in behaviour.

Where appropriate, a standardised mood questionnaire may help track symptoms over time.

You should also discuss difficulties with eating adequately, managing side effects or taking medication as prescribed.

Some people report positive changes in wellbeing during weight management, but improvements in depression should not be assumed.

The purpose of monitoring is to assess your individual response and identify concerns that may require further attention.

Ongoing Treatment: Maintaining Mental Health Stability

Once you're established on treatment, continuing to look after your mental health remains important.

Recognising Your Personal Warning Signs

Depression can affect people differently.

For some, sleep changes or social withdrawal may be early warning signs.

Others notice increasing irritability, low motivation or negative thinking.

If you've experienced depression before, you may recognise patterns that suggest your symptoms are returning.

Keeping a simple mood diary may be helpful if you find it useful.

However, mood tracking is optional and should not become another source of anxiety.

If you notice significant changes, discuss them with your GP or mental health professional.

Managing Medication Interactions

If you're taking antidepressants alongside weight loss medication, your prescriber should review your complete medication list.

GLP-1-based medicines delay gastric emptying, which may affect the absorption of some oral medicines.

The clinical significance depends on the medication involved.

There is no universal requirement to change antidepressant doses when starting Wegovy or Mounjaro.

However, vomiting, persistent gastrointestinal symptoms or changes in your ability to take oral medication may require assessment.

If either your antidepressant or weight-management treatment changes, inform the relevant healthcare professionals.

For further information, see our guide on taking weight loss injections with antidepressants.

Lifestyle Factors That Support Both Weight Loss and Mental Health

Certain lifestyle measures may support physical and mental wellbeing.

Sleep is important, particularly because depression can affect sleep quality and duration.

Maintaining a consistent sleep routine may be helpful, although persistent sleep problems deserve medical assessment.

Physical activity can also support mental health.

NICE includes group exercise among the treatment options for depression, but the appropriate approach depends on symptom severity and individual circumstances.

Gentle activities such as walking may be a manageable starting point.

Social connections can provide valuable emotional support.

Maintaining relationships and activities you enjoy may help protect your wellbeing during treatment.

Nutrition also matters.

GLP-1 medicines can reduce appetite, so it's important to maintain adequate food and fluid intake.

Vitamins and minerals, including B12, vitamin D and iron, are important for normal health, but supplementation is not automatically necessary for everyone taking weight loss medication.

Our Vitamin B12 Spray and Vitamin D3 Spray are available as supplement options.

However, they should not be presented as treatments for depression or as guaranteed ways to improve mood during weight loss.

Supplementation should be based on individual nutritional needs and appropriate clinical advice.

When Life Stressors Arise

Even when depression is well managed, difficult life events can affect mental health.

Bereavement, relationship difficulties, work stress or other challenges may contribute to changes in mood.

During these periods, additional support may be helpful.

This could include contacting your GP, speaking with your therapist or reviewing your existing mental health care plan.

Significant stress does not automatically mean you need to stop weight loss medication.

Any decision to pause or discontinue treatment should be made with your prescriber after considering your circumstances.

The Psychological Journey of Weight Loss With Depression

Weight loss can involve physical and psychological changes.

However, individual experiences vary, and not everyone experiences significant emotional adjustments.

Identity and Body Image Shifts

Changes in weight and appearance may influence how you feel about your body.

Some people experience improved confidence, while others find that existing body image concerns remain.

It would be inaccurate to suggest that significant weight loss routinely causes an identity crisis or a period of grieving for a previous appearance.

However, if changes in body image are distressing, psychological support may be helpful.

For someone with depression, it is important not to assume that changing body weight will automatically resolve negative beliefs about themselves.

Relationship Dynamics

Changes in lifestyle or appearance may influence relationships, but this isn't inevitable.

Some people find that friends and family are supportive throughout treatment.

Others may experience uncomfortable comments or differing expectations.

If this happens, open communication and appropriate boundaries may help.

However, it would be misleading to suggest that partners commonly feel threatened by weight loss or that relationship difficulties are an expected consequence of treatment.

Unrealistic Expectations and Disappointment

When you've struggled with both depression and weight, it's understandable to hope that weight loss will improve several areas of your life.

Weight management may provide physical health benefits and improve quality of life for some people.

However, weight loss is not a treatment for clinical depression.

It cannot be relied upon to improve mood, resolve relationship difficulties or address underlying psychological concerns.

If you have depression, continuing appropriate mental health treatment remains important regardless of changes in weight.

Setting realistic expectations can help you evaluate progress in a balanced way.

Building Sustainable Self-Care Practices

Weight-management treatment may provide an opportunity to develop habits that support overall health.

These might include regular meals, physical activity, consistent sleep routines and enjoyable social activities.

However, managing depression can make everyday routines more difficult at times.

A flexible approach is often more realistic than expecting consistent progress every day.

The aim is to support your physical and psychological wellbeing without creating unnecessary pressure.

When Concerns Arise: Knowing When to Seek Help

Although the MHRA's review did not find evidence supporting a causal association between GLP-1 medicines and depression or suicidal thoughts, individual mental health concerns still require appropriate attention.

Warning Signs That Need Immediate Attention

Thoughts of suicide, plans to harm yourself or feeling unable to keep yourself safe require urgent help.

If you're in immediate danger, call 999 or attend A&E.

If you need urgent mental health support but there is no immediate danger, contact NHS 111 and select the mental health option.

You can find more information in the NHS guidance on getting urgent help for mental health.

If you're already receiving care from a mental health team, contact them using the crisis arrangements in your care plan.

Do not wait for your next weight-management appointment.

Your safety and access to appropriate mental health treatment should take priority.

Less Urgent but Important Concerns

Other symptoms may not require emergency treatment but should still be discussed promptly with a healthcare professional.

These include persistent low mood, increased anxiety, significant sleep disturbances, loss of interest in activities or difficulties managing daily responsibilities.

If your symptoms have changed since starting weight loss medication, tell your prescriber.

They can consider possible contributing factors and whether further assessment is needed.

Adjusting Treatment Plans

If mental health concerns arise, your healthcare team may review your treatment plan.

Depending on the circumstances, this could involve additional mental health support, medication review or changes to weight-management treatment.

However, reducing the dose or pausing GLP-1 medication should not be presented as an established treatment for depression symptoms.

Any changes should follow the medicine's prescribing guidance and an individual clinical assessment.

If treatment is discontinued, your clinician can discuss appropriate next steps.

Long-Term Success: Sustaining Both Weight Loss and Mental Health

Long-term weight management involves considering treatment benefits, side effects, lifestyle and overall wellbeing.

For someone with depression, continued mental health care may also be important.

Duration of Treatment Considerations

Some people regain weight after stopping GLP-1-based weight-management medication.

Longer-term treatment may therefore be appropriate for certain patients, depending on the medicine, clinical response and prescribing guidance.

However, it would be inaccurate to claim that everyone needs lifelong treatment.

There is also insufficient evidence to guarantee that mental health risks remain unchanged with longer treatment duration or that depression consistently improves over time.

Ongoing clinical review should consider both physical and psychological health.

Integrating Weight Management Into Your Life

Sustainable weight management generally involves finding approaches that fit your health needs and everyday circumstances.

This may include enjoyable physical activity, balanced nutrition and flexible routines.

For someone with depression, overly restrictive or demanding plans may be difficult to maintain.

The aim should be to support long-term health rather than expecting perfection.

Continued Mental Health Support

If you're receiving treatment for depression, continue following your agreed care plan.

This may involve antidepressant medication, psychological therapy or ongoing reviews with your GP or mental health team.

Do not stop antidepressants because you've lost weight or noticed improvements in mood without discussing this with your prescriber.

Weight-management treatment and depression treatment address different clinical needs.

Both may require ongoing attention.

Making Your Decision: Is Now the Right Time?

Deciding whether to start weight loss medication involves considering your overall health and treatment goals.

If you have depression, it may help to think about your current symptoms, existing support and ability to manage potential medication side effects.

You may also want to discuss whether your current medications require review and whether weight-management treatment is appropriate for your circumstances.

However, having depression does not automatically mean you are unsuitable for treatment.

Nor is there a universal requirement to complete psychological therapy or achieve a particular period of mental health stability before starting.

The decision should be based on individual clinical assessment, licensed prescribing criteria and the potential benefits and risks.

If you're uncertain, discuss your concerns with your GP, mental health professional or weight-management prescriber.

If you have additional health considerations, such as cardiovascular or gastrointestinal conditions, our specialised support services provide information about individualised weight-management assessment.

Moving Forward With Confidence and Support

Starting weight loss treatment when you live with depression may be possible.

A mental health diagnosis does not automatically exclude you from receiving Wegovy or Mounjaro, provided you meet the relevant prescribing criteria and treatment is clinically appropriate.

The MHRA's review of GLP-1 medicines found that the available evidence did not support a causal association with depression, suicidal ideation or suicide.

However, this does not remove the importance of monitoring your mental health and seeking support if symptoms change.

Your depression is one part of your wider medical history, and it should be considered alongside your physical health, medications and treatment goals.

Weight loss may support certain aspects of physical wellbeing, but it is not a substitute for appropriate depression treatment.

At Bodyline Clinic, our team considers relevant medical history and mental health concerns when assessing treatment suitability.

Where additional specialist input or coordination is needed, this should form part of the clinical decision-making process.

Book a no-obligation consultation today to discuss whether medical weight management may be appropriate for you.

Whether you prefer online consultations or in-person appointments, our aim is to help you make informed decisions about your health and treatment options.

About The Author

Sally-Anne Turner

I am founder and Managing Director of Bodyline, with over two decades of experience in the healthcare and wellness industries. I combine a deep understanding of medical wellness with a passion for science-backed health solutions and future-focused care. I have a specialist interest in developing gold standard clinical services for medical weight loss, including the latest GLP-1 medications, hormone health, and low-dose naltrexone (LDN) treatments.

Related Blog Posts